Maxlinear Inc expected to post a loss of 5 cents a share - Earnings Preview

Reuters
04-22
Maxlinear Inc <mxl.oq> expected to post a loss of 5 cents a share - Earnings Preview </mxl.oq>
  • Maxlinear Inc MXL.OQ MXL.O is expected to show a fall in quarterly revenue when it reports results on April 23 for the period ending March 31 2025

  • The Carlsbad California-based company is expected to report a 0.3% decrease in revenue to $94.988 million from $95.27 million a year ago, according to the mean estimate from 10 analysts, based on LSEG data.The company's guidance on January 29 2025, for the period ended March 31, was for revenue between $85.00 million and $105.00 million.

  • ​LSEG's mean analyst estimate for Maxlinear Inc is for a loss of 5 cents per share.

  • The current average analyst rating on the shares is "hold" and the breakdown of recommendations is 4 "strong buy" or "buy," 7 "hold" and no "sell" or "strong sell."

  • The mean earnings estimate of analysts was unchanged in the last three months. ​

  • Wall Street's median 12-month price target for Maxlinear Inc is $19.00​, above​ its last closing price of $10.22. ​​​

The company's guidance on January 29 2025 for the period ended March 31 was for gross profit margin between USD57.5% and USD60.5%.

Previous quarterly performance (using preferred earnings measure in US dollars). ​

QUARTER ENDING

STARMINESMARTESTIMATE®

LSEG IBES ESTIMATE

ACTUAL

BEAT, MET, MISSED

SURPRISE %

Dec. 31 2024

-0.12

-0.13

-0.09

Beat

29.2

Sep. 30 2024

-0.32

-0.32

-0.36

Missed

-11.3

Jun. 30 2024

-0.20

-0.19

-0.25

Missed

-28.6​

Mar. 31 2024

-0.21

-0.22

-0.21

Beat

3.2

​​Dec. 31 2023

0.01

0.01

0.01

Met

28.5

Sep. 30 2023

0.04

0.04

0.02

Missed

-45.9​

Jun. 30 2023

0.33

0.33

0.34

Beat

1.8

Mar. 31 2023

0.70

0.70

0.74

Beat

5.2

This summary was machine generated April 21 at 20:22 GMT. All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10